ing, and if adequate proof of participation is not available, claims are evaluated under the nonpresumptive regulation and a dose reconstruction is required. The committee does not know how often claims for compensation for presumptive diseases have had to be evaluated under the nonpresumptive regulation, but the number of such cases could increase in the future, given the expansion of the list of presumptive diseases, thus increasing the importance of changes in methods of dose reconstruction.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement